Kerry Associates is pleased to announce that it has entered into joint venture negotiations with a Cellulose Ethanol Technology Company on behalf of Amelot Holdings, Inc (Pink Sheets: AMHD). Cellulose technology is one of the world's most efficient, renewable energy technologies for the production of ethanol and electricity (green power) from organic waste. This technology produces ethanol from any solid, non-hazardous, cellulosic waste material which is then segregated from other waste materials. Eric Cousens, President of Kerry Associates, stated "We have performed extensive research on different ethanol production technologies all over the world, and have chosen to enter into joint venture negotiations with this specific technology company. This technology solves many problems facing the world's energy crisis that is affecting all of us. With this technology, we can turn the worlds waste into energy of the future. A major setback in the technologies we have researched shows that there is just not enough feed stock to supply the demand of conventional dry mill ethanol plants, and the cost of feed is not economically sound. Statistics show the demand of feed stock exceeds the current national supply. With this technology, our everyday trash such as used tires, sewer sludge, plastics and other Municipal Solid Waste (MSW) can be turned into ethanol. America generates 240 million tons of MSW per year. The carbon in America's available municipal wastes alone is enough to create 16 billion gallons of ethanol annually." About Amelot Holdings, Inc. Amelot Holdings, Inc. is a diversified holding company focused on acquiring under-valued, high-growth firms and properties in the natural resource industry. For more information on Amelot Holdings Inc. Please Visit: www.amelotholdings.com About Kerry Associates, Inc. Kerry Associates Inc. is a business consulting firm helping companies develop and expand into emerging markets while strategically executing their objectives. Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing and access funds from our existing financing arrangements that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events.
HLK Biotech (CE) (USOTC:AMHD)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more HLK Biotech (CE) Charts.
HLK Biotech (CE) (USOTC:AMHD)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more HLK Biotech (CE) Charts.